Form 10-Q · Quarterly report
GE HealthCare 10-Q, filed Oct 28, 2026
- Filed
- CIK
- 0001932393
- Accession no.
- 0001932393-26-000059
Summary
GE HealthCare reported third-quarter 2026 revenue of $5.51 billion, up 7.2% as reported and 6.2% organically from a year earlier, with net income attributable to GE HealthCare of $615 million versus $446 million. For the first nine months of 2026, revenue was $15.94 billion, up 6.8% as reported and 4.2% organically.
Key points
- Third-quarter sales of products rose 6.7% to $3.60 billion and sales of services rose 8.1% to $1.91 billion.
- The Advanced Imaging Solutions (AIS) segment grew 6.1% to $3.87 billion, Pharmaceutical Diagnostics (PDx) grew 13.0% to $846 million, and Patient Care Solutions (PCS) grew 8.5% to $793 million in the quarter.
- USCAN revenue rose 13.3% to $2.67 billion, EMEA fell 0.4% to $1.35 billion, China region rose 7.1% to $586 million, and Rest of World rose 2.6% to $901 million in the quarter.
- Quarterly operating income was $805 million, up 23.3% from $653 million a year earlier, and adjusted EBIT was $913 million.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
ITEM 2. MANAGEMENT’S DISCUSSION RESULTS OF OPERATIONS The following tables set forth our results of operations for each of the periods presented. Condensed Consolidated Statements of Income (Unaudited) For the three months ended September 30 For the nine months ended September 30 2026 2025 2026 2025 Sales of products $ 3,602 $ 3,375 $ 10,364 $ 9,755 Sales of services 1,911 1,769 5,575 5,172 Total revenues 5,513 5,143 15,939 14,927 Cost of products 2,373 2,270 6,873 6,392 Cost of services 916 884 2,685 2,549 Gross profit 2,224 1,990 6,381 5,987 Selling, general, and administrative 1,100 1,045 3,334 3,114 Research and development 320 292 988 937 Total operating expenses 1,419 1,337 4,322…
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.